Page last updated: 2024-08-25

dienogest and Ovarian Diseases

dienogest has been researched along with Ovarian Diseases in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's12 (85.71)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Fujimoto, A; Honda, M; Isono, W; Matsuyama, R; Nishii, O; Saito, A; Tsuchiya, A; Tsuchiya, H1
Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S1
Arena, A; Caprara, G; Del Forno, S; Mabrouk, M; Matteucci, C; Paradisi, R; Seracchioli, R; Zannoni, L1
Cho, S; Kim, SH; Lee, DY; Lee, SR; Seo, SK; Song, JY; Yi, KW1
Aylamazyan, E; Gzgzyan, A; Kogan, I; Muller, V; Niauri, D; Yarmolinskaya, M1
Choi, D; Kim, SE; Lee, DY; Seo, JW; Yoon, BK1
Arena, A; Del Forno, S; Giaquinto, I; Mabrouk, M; Mattioli, G; Paradisi, R; Seracchioli, R1
Angioni, S; Cela, V; Litta, P; Luisi, S; Malune, ME; Nappi, L; Pontis, A; Vignali, M1
Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Svelato, A; Tonni, G1
Kurabayashi, T; Tamura, M; Tsuneki, I; Yanase, T1
Hayashi, A; Hayashi, M; Kyo, S; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Yamashita, Y1
Adachi, K; Fujitani, M; Kimura, T; Kobayashi, E; Miyoshi, Y; Nakamura, K; Otake, A; Sasamoto, N; Sawada, K; Shioji, M; Takahashi, K; Tokuhira, A; Wakimoto, A; Yamamoto, Y; Yoshimura, A1
Kitawaki, J; Kusuki, I; Mita, S; Mizuguchi, K; Shimizu, Y; Suganuma, I; Xu, B; Yamanaka, K1
Fu, L; Hirata, T; Hirota, Y; Morimoto, C; Osuga, Y; Taketani, Y; Yano, T1

Trials

2 trial(s) available for dienogest and Ovarian Diseases

ArticleYear
Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5

    Topics: Adult; Endometriosis; Endometrium; Female; Humans; Inflammation; Middle Aged; Nandrolone; Ovarian Diseases; Prospective Studies; Treatment Outcome; Young Adult

2018
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:4

    Topics: Adolescent; Adult; Combined Modality Therapy; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laparoscopy; Nandrolone; Norpregnenes; Ovarian Diseases; Secondary Prevention; Treatment Outcome; Young Adult

2013

Other Studies

12 other study(ies) available for dienogest and Ovarian Diseases

ArticleYear
Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study.
    Journal of medical case reports, 2019, Oct-22, Volume: 13, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Adult; Age Factors; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Ovarian Neoplasms; Parity; Retrospective Studies; Risk Factors

2019
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 216

    Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome

2017
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.
    Reproductive sciences (Thousand Oaks, Calif.), 2018, Volume: 25, Issue:3

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome; Ultrasonography; Young Adult

2018
Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:sup1

    Topics: Adult; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Ovarian Diseases; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome

2017
Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 236

    Topics: Adult; Contraceptives, Oral, Combined; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nandrolone; Ovarian Diseases; Prospective Studies; Secondary Prevention; Young Adult

2019
Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?
    European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 238

    Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Ovarian Diseases; Retrospective Studies

2019
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:1

    Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Pelvic Pain; Treatment Outcome; Young Adult

2020
Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:11

    Topics: Adult; Drug Administration Schedule; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Treatment Outcome; Uterine Hemorrhage; Young Adult

2014
Decorin induced by progesterone plays a crucial role in suppressing endometriosis.
    The Journal of endocrinology, 2014, Volume: 223, Issue:2

    Topics: Adult; Cell Cycle; Cells, Cultured; Cross-Sectional Studies; Decorin; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Progesterone; Retrospective Studies; Transcriptional Activation; Young Adult

2014
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:8

    Topics: Adult; Disease-Free Survival; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Japan; Laparoscopy; Nandrolone; Outcome Assessment, Health Care; Ovarian Diseases; Pain Measurement; Pelvic Pain; Recurrence; Retrospective Studies

2016
Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
    Fertility and sterility, 2012, Volume: 97, Issue:2

    Topics: Adult; Aromatase; Aromatase Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Nandrolone; NF-kappa B; Ovarian Diseases; Ovary; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spheroids, Cellular; Stromal Cells; Young Adult

2012
Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells.
    Fertility and sterility, 2008, Volume: 89, Issue:5 Suppl

    Topics: Adult; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cells, Cultured; Contraceptives, Oral; DNA; Drug Evaluation, Preclinical; Endometriosis; Female; G1 Phase; Humans; Nandrolone; Ovarian Diseases; Resting Phase, Cell Cycle; Stromal Cells

2008